Perspectives in Urology:
Point-Counterpoint2009

November 5–7, 2009

The Scottsdale Plaza
 Scottsdale, Arizona

Perspectives in Urology: Point-Counterpoint 2009 Reference Materials

Thank you for registering for Perspectives in Urology: Point-Counterpoint 2009!

Below are materials (in PDF form) for the sessions to be presented. We are no longer providing printed coursebooks onsite, although a printing station will be available to print limited quantity materials.

We encourage you to bring a laptop to view materials, or to print the handouts for the sessions that you plan to attend.

Full Coursebook
Full Perspectives In Urology Coursebook - 361 pages
Reference Materials by Day
Coursebook Introduction with:
  • CME information
  • Faculty Bios
  • Agenda
Thursday, October 5, 2009 FULL DAY
Friday, October 6, 2009 FULL DAY
Saturday, October 7, 2009 FULL DAY

Reference Materials by Session
Thursday, October 5, 2009
8:00 – 8:30 am
 The Role of Robotics in Urologic Surgery Paul D. Maroni, MD
8:30 – 9:00 am
 Point-Counterpoint: Prostate Cancer
Includes:

Robotic Surgery is Hype ~ E. David Crawford, MD

Robotic Surgery is the Mainstream ~ Paul D. Maroni, MD

9:10 – 9:30 am Histologic Subtypes of Renal Cell Carcinoma
 ~ M. Scott Lucia, MD
9:30 – 9:55 am Point-Counterpoint: Small Renal Masses

Best to Remove ~ Paul D. Maroni, MD

Best to Watch ~ Donald L. Lamm, MD
10:15 – 11:15 am Female Urology “Potpourri”
 ~ Brian J. Flynn, MD
Friday, October 6, 2009
8:00 – 8:45 am A Case-based Approach to the Management of Bladder Cancer
 Moderator:
Robert Donohue, MD
Panel:
David C. Beyer, MD • E. David Crawford, MD
Donald L. Lamm, MD • Paul D. Maroni, MD
9:00 – 9:30 am Non-muscle Invasive Bladder Cancer, including Chemoprevention ~ Review of Existing Guidelines & International Recommendations
 ~ Donald L. Lamm, MD
9:30 – 9:55 am Point-Counterpoint: Radiation & Bladder Cancer
1. Radiation Has No Role in the Treatment of Any Stage of Bladder Cancer
2. Radiation Plays a Major Role in Certain Stages of Bladder Cancer
 1. ~ Robert E. Donohue, MD

2. ~ David C. Beyer, MD
10:15 – 10:35 am What the Community Urologist Needs to Know About BCG
 ~ Donald L. Lamm, MD
10:45 – 11:15 am The Spectrum of Stress Incontinence Surgery, 2009
 ~ Brian J. Flynn, MD
1:00 – 1:20 pm Challenges in Prostate Cancer: Why We Are 15 Years Behind Breast Cancer ~ David C. Beyer, MD
1:20 – 1:50 pm Clinical and Pathologic Characteristics of Prostate Cancer (including new markers such as PCA3)
 ~ M. Scott Lucia, MD
1:50 – 2:10 pm Chemoprevention Strategies ~ M. Scott Lucia, MD
2:10 – 2:40 pm Point-Counterpoint:
1. Early Detection of Prostate Cancer Is Not Valuable In a Lot of Men
2. We Can’t Go Backwards – Of Course Screening Has Saved Lives
 1. ~ E. David Crawford, MD

2. ~ Robert E. Donohue, MD
3:00 – 3:20 pm What’s New in Advanced Disease
 ~ Matthew Rettig, MD
3:20 – 3:50 pm An Update on Radiation Therapy for Prostate Cancer
 ~ David C. Beyer, MD
Saturday, October 7, 2009
8:00 – 8:20 am Chemotherapy for Urological Cancers
 ~ Matthew Rettig, MD
8:25 – 8:55 am Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP ~ E. David Crawford, MD
8:55 – 9:25 am Point-Counterpoint
1. Are We Ignoring Level One Evidence by Not Prescribing Appropriate Medical Therapy?
2. Alternative Medicine Should Be the Choice 		1. ~ E. David Crawford, MD

2. ~ Mark A. Moyad, MD, MPH
Crawford
N/A

Download
Moyad
9:35 – 10:05 am Increasing Awareness, Diagnosis, and Treatment of Hypogonadism ~ Jacob Rajfer, MD
10:05 – 10:35 am Point-Counterpoint: Late Onset Hypogonadism (LOH)

1. We are Under-diagnosing and Treating Men with LOH

2. LOH is a Non-existent Disease

 1. ~ Jacob Rajfer, MD

2. ~ Robert E. Donohue, MD
10:55 – 11:55 am Fad Diets and Dietary Supplements for Urology Patients:
What Works and What’s Worthless
 ~ Mark A. Moyad, MD, MPH
11:55 – 12:10 pm Pills and Tests: What Should I (the urologist) Be Taking and Getting?
 ~ Mark A. Moyad, MD, MPH
12:10 – 12:30 pm Point-Counterpoint:

1. Why Every Man Should Be Offered Chemoprevention for Prostate Cancer

2. Chemoprevention Is Not for Every Man

 ~ E. David Crawford, MD

~ Mark A. Moyad, MD, MPH

Return to top